Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. — CFSMEATLAS
Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms.
Sulheim, Dag, Hurum, Harald, Helland, Ingrid B et al. · BioPsychoSocial medicine · 2012 · DOI
Quick Summary
This study followed 47 teenagers with ME/CFS over several months to see how they changed over time. Researchers found that most teens improved in their symptoms—including fatigue, pain, and brain fog—and these improvements happened at the same time their heart and nervous system function also improved. This suggests that problems with how the body regulates heart rate and blood pressure may be connected to ME/CFS symptoms.
Why It Matters
This study provides evidence that autonomic nervous system dysfunction in adolescent ME/CFS is not static but improves alongside clinical recovery, suggesting that addressing circulatory abnormalities may be therapeutically relevant. The correlation between symptom improvement and objective cardiovascular changes strengthens the case that ME/CFS has biological underpinnings rather than being purely psychological.
Observed Findings
Majority of adolescents showed significant improvements in functional impairment, fatigue severity, muscular pain, concentration problems, post-exertional malaise, and non-relieving rest.
Baseline heart rate, blood pressure, total peripheral resistance index, and sympathovagal balance (LF/HF ratio) were significantly lower at follow-up visit.
Cardiovascular responses during tilt testing (increases in heart rate, mean blood pressure, diastolic blood pressure, and total peripheral resistance) were significantly less pronounced at follow-up.
Significant correlations existed between changes in autonomic symptom score, fatigue severity score, and functional impairment score from first to second visit.
Inferred Conclusions
Autonomic cardiovascular abnormalities in adolescent CFS are reversible and improve concurrently with clinical symptoms.
A possible pathophysiological connection exists between abnormal autonomic control and the clinical manifestations of CFS in adolescents.
Improvement in CFS is achievable in adolescents, suggesting a more favorable prognosis than previously uncertain.
Remaining Questions
What specific interventions or natural recovery mechanisms drove the improvements observed?
Do the same patterns of concurrent autonomic and symptom improvement occur in adults with ME/CFS?
What This Study Does Not Prove
This study does not prove that autonomic dysfunction *causes* ME/CFS symptoms—only that they improve together. The small sample size and lack of a control group limit generalizability, and the wide range of follow-up times (3-17 months) makes it unclear what timeline of improvement is typical. The study does not identify what triggered the improvements observed.